A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia
Peripheral artery disease (PAD) is one of the major vascular complications in individuals suffering from diabetes and in the elderly that can progress to critical limb ischemia (CLI), portending significant burden in terms of patient morbidity and mortality. Over the last two decades, stem cell ther...
Saved in:
Main Authors: | Punam P. Parikh, Zhao-Jun Liu, Omaida C. Velazquez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2017/3750829 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell Therapy in Patients with Critical Limb Ischemia
by: Rita Compagna, et al.
Published: (2015-01-01) -
Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials
by: Baocheng Xie, et al.
Published: (2018-01-01) -
Our Treatment Strategy for Critical Limb Ischemia
by: Tetsuo Yamada, et al.
Published: (2013-01-01) -
Clinical Efficacy and Meta-Analysis of Stem Cell Therapies for Patients with Brain Ischemia
by: Lukui Chen, et al.
Published: (2016-01-01) -
Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia
by: Vijay Murali Ravi Mythili, et al.
Published: (2025-01-01)